Is Canagliflozin Cost-Effective Compared to Sitagliptin Across Multiple Lines of Type 2 Diabetes Mellitus (T2dm) Therapy In Ireland?
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.699
https://www.valueinhealthjournal.com/article/S1098-3015(14)02629-1/fulltext
Title :
Is Canagliflozin Cost-Effective Compared to Sitagliptin Across Multiple Lines of Type 2 Diabetes Mellitus (T2dm) Therapy In Ireland?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02629-1&doi=10.1016/j.jval.2014.08.699
First page :
A345
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
123